NasdaqGM - Nasdaq Real Time Price USD
Veracyte, Inc. (VCYT)
32.14
+0.67
+(2.15%)
At close: April 24 at 4:00:00 PM EDT
32.14
0.00
(0.00%)
After hours: April 24 at 5:22:06 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 415,197 | 14 |
| Sales | 172,827 | 17 |
| Net Shares Purchased (Sold) | 242,370 | 31 |
| Total Insider Shares Held | 519.11k | -- |
| % Net Shares Purchased (Sold) | 87.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEITE JOHN Officer | Sale at price 31.04 - 31.96 per share. | Direct | 234,630 | Mar 7, 2025 |
| STAPLEY MARC A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
| WYGANT JONATHAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
| FEBBO PHILLIP G Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
| CHAMBERS REBECCA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
| MCGUIRE ANNIE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
| LEITE JOHN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
| FEBBO PHILLIP G Officer | Sale at price 32.86 - 33.95 per share. | Direct | 268,013 | Mar 4, 2025 |
| MCGUIRE ANNIE General Counsel | Sale at price 33.69 per share. | Direct | 38,476 | Mar 4, 2025 |
| STAPLEY MARC A Chief Executive Officer | Sale at price 32.82 - 34.37 per share. | Direct | 1,756,855 | Mar 4, 2025 |
| STAPLEY MARC A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| FEBBO PHILLIP G Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| CHAMBERS REBECCA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| MCGUIRE ANNIE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| LEITE JOHN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| LEITE JOHN Officer | Sale at price 33.84 per share. | Direct | 194,445 | Feb 27, 2025 |
| CHAMBERS REBECCA Chief Financial Officer | Sale at price 43.85 per share. | Direct | 23,109 | Feb 3, 2025 |
| EPSTEIN ROBERT S Director | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 160,800 | Jan 6, 2025 |
| EASTHAM KARIN Director | Sale at price 40.12 - 40.50 per share. | Direct | 403,006 | Jan 2, 2025 |
| EASTHAM KARIN Director | Conversion of Exercise of derivative security at price 5.28 per share. | Direct | 52,800 | Jan 2, 2025 |
| STAPLEY MARC A Chief Executive Officer | Sale at price 43.37 - 44.14 per share. | Direct | 242,737 | Dec 13, 2024 |
| FEBBO PHILLIP G Officer | Sale at price 44.09 per share. | Direct | 173,447 | Dec 4, 2024 |
| MCGUIRE ANNIE General Counsel | Sale at price 44.02 per share. | Direct | 823,179 | Dec 4, 2024 |
| CHAMBERS REBECCA Chief Financial Officer | Sale at price 43.23 per share. | Direct | 302,622 | Dec 3, 2024 |
| LEITE JOHN Officer | Sale at price 43.25 per share. | Direct | 45,408 | Dec 3, 2024 |
| WYGANT JONATHAN Officer | Sale at price 43.36 per share. | Direct | 41,452 | Dec 3, 2024 |
| WYGANT JONATHAN Officer | Sale at price 42.89 per share. | Direct | 215,834 | Nov 27, 2024 |
| EASTHAM KARIN Director | Sale at price 36.77 - 38.76 per share. | Direct | 564,768 | Nov 19, 2024 |
| CHAMBERS REBECCA Chief Financial Officer | Sale at price 38.34 per share. | Direct | 585,663 | Nov 12, 2024 |
| EPSTEIN ROBERT S Director | Sale at price 38.32 per share. | Direct | 574,830 | Nov 12, 2024 |
| EPSTEIN ROBERT S Director | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 120,600 | Nov 12, 2024 |
| JONES EVAN Director | Sale at price 35.23 per share. | Indirect | 182,263 | Sep 19, 2024 |
| LEITE JOHN Officer | Sale at price 29.78 per share. | Direct | 163,159 | Sep 4, 2024 |
| SHAFER DAVID BRENT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| MILLER THOMAS F Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| JONES EVAN Director | Sale at price 30.00 - 32.77 per share. | Indirect | 1,540,366 | Aug 13, 2024 |
| JONES EVAN Director | Conversion of Exercise of derivative security at price 10.41 per share. | Direct | 88,339 | Aug 13, 2024 |
| JONES EVAN Director | Sale at price 30.03 per share. | Indirect | 53,391 | Aug 9, 2024 |
| JONES EVAN Director | Conversion of Exercise of derivative security at price 10.41 per share. | Direct | 3,123 | Aug 9, 2024 |
| HOLSTEIN JENS Director | Sale at price 28.00 - 30.00 per share. | Direct | 145,000 | Aug 7, 2024 |
| JONES EVAN Director | Sale at price 30.32 per share. | Direct | 154,883 | Aug 7, 2024 |
| JONES EVAN Director | Sale at price 30.32 per share. | Indirect | 154,883 | Aug 7, 2024 |
| JONES EVAN Director | Conversion of Exercise of derivative security at price 10.41 per share. | Direct | 12,638 | Aug 7, 2024 |
| JONES EVAN Director | Conversion of Exercise of derivative security at price 10.41 per share. | Direct | 12,638 | Aug 7, 2024 |
| HOLSTEIN JENS Director | Sale at price 24.00 - 25.00 per share. | Direct | 122,500 | Jul 16, 2024 |
| LEITE JOHN Officer | Sale at price 25.00 per share. | Direct | 31,925 | Jul 16, 2024 |
| EASTHAM KARIN Director | Sale at price 25.00 per share. | Direct | 187,500 | Jul 16, 2024 |
| EASTHAM KARIN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| JONES EVAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| EPSTEIN ROBERT S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
Related Tickers
PSNL Personalis, Inc.
3.8300
+4.08%
GH Guardant Health, Inc.
47.41
+3.88%
NTRA Natera, Inc.
154.48
+3.98%
EXAS Exact Sciences Corporation
45.60
+3.42%
MYGN Myriad Genetics, Inc.
7.37
+1.10%
CDNA CareDx, Inc
18.49
+3.64%
TWST Twist Bioscience Corporation
40.17
+6.78%
CSTL Castle Biosciences, Inc.
20.93
-1.60%
01P.F Medpace Holdings, Inc.
265.50
+3.79%
WGS GeneDx Holdings Corp.
109.39
+3.50%